SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-006781
Filing Date
2021-02-19
Accepted
2021-02-19 07:03:49
Documents
14
Period of Report
2021-02-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20210219.htm   iXBRL 8-K 37738
2 EX-99.1 acor-ex991_8.htm EX-99.1 12010
3 GRAPHIC gp5j0gnpsfqq000001.jpg GRAPHIC 15708
  Complete submission text file 0001564590-21-006781.txt   202589

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acor-20210219.xsd EX-101.SCH 5768
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20210219_lab.xml EX-101.LAB 18732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20210219_pre.xml EX-101.PRE 11167
7 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20210219_htm.xml XML 3419
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 21652017
SIC: 2836 Biological Products, (No Diagnostic Substances)